FDA issued a warning letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA 483 Warning Letters Manufacturing ERP Software